Harry G. Kerasidis is an expert in the field of Neurology. He attended Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49/84 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification". Harry G. Kerasidis, MD is also published. He has 6 publications published. The lastest publication: "Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats.' He is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1982665378 | |
NPPES Provider LastName | KERASIDIS | |
NPPES Provider FirstName | HARRY | |
NPPES Provider ZIPCode | 206784015 | |
NPPES Provider State | MD | |
Specialty Description | Neurology | |
Total Claim Count | 1561.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 87.0 | |
Percent Opioid Claims | 5.57 |
National Provider Identifier [NPI] | 1982665378 |
Last Name Of The Provider | KERASIDIS |
First Name Of The Provider | HARRY |
View All |
![]() |
Dr. Eric E. Floranda, MD
![]() |
![]() |
Dr. Ahmed H. Kafaji, MD |
![]() |
Dr. Shoba Mathews, MD
![]() |